Cell Reports (May 2019)

Sterile Lung Inflammation Induced by Silica Exacerbates Mycobacterium tuberculosis Infection via STING-Dependent Type 2 Immunity

  • Sulayman Benmerzoug,
  • Badreddine Bounab,
  • Stéphanie Rose,
  • David Gosset,
  • Franck Biet,
  • Thierry Cochard,
  • Aurore Xavier,
  • Nathalie Rouxel,
  • Louis Fauconnier,
  • William G.C. Horsnell,
  • Bernhard Ryffel,
  • Dieudonnee Togbe,
  • Valerie F.J. Quesniaux

Journal volume & issue
Vol. 27, no. 9
pp. 2649 – 2664.e5

Abstract

Read online

Summary: Lung inflammation induced by silica impairs host control of tuberculosis, yet the underlying mechanism remains unclear. Here, we show that silica-driven exacerbation of M. tuberculosis infection associates with raised type 2 immunity. Silica increases pulmonary Th2 cell and M2 macrophage responses, while reducing type 1 immunity after M. tuberculosis infection. Silica induces lung damage that prompts extracellular self-DNA release and activates STING. This STING priming potentiates M. tuberculosis DNA sensing by and activation of cGAS/STING, which triggers enhanced type I interferon (IFNI) response and type 2 immunity. cGAS-, STING-, and IFNAR-deficient mice are resistant to silica-induced exacerbation of M. tuberculosis infection. Thus, silica-induced self-DNA primes the host response to M. tuberculosis-derived nucleic acids, which increases type 2 immunity while reducing type 1 immunity, crucial for controlling M. tuberculosis infection. These data show how cGAS/STING pathway activation, at the crossroads of sterile inflammation and infection, may affect the host response to pathogens such as M. tuberculosis. : Benmerzoug et al. mechanistically dissect how sterile lung inflammation induced by silica exacerbates M. tuberculosis infection (silicotuberculosis). Silica exposure induces self-dsDNA release and STING pathway activation, which potentiate the host response to M. tuberculosis DNA via initiation of type 2 immunity. Thus, STING and nucleic acids represent interesting therapeutic targets for silicotuberculosis.